Free tool
Oncology stocks
We cover 8 companies grouped under the Oncology theme. The median market value in the group is $16.28M. Across the group, the median move over the past trading day is +2.04%. Price change over the past year runs from −36.7% to +278.3% across the middle 80 percent of the group, with a median of +25.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +318.64% |
| HOWL | Werewolf Therapeutics, Inc. | $42.93M | Micro cap | −35.04% |
| KYNB | Kyntra Bio, Inc. | $32.80M | Micro cap | −23.80% |
| BFRI | Biofrontera Inc. | $22.43M | Micro cap | +63.77% |
| APRE | Aprea Therapeutics, Inc. | $10.14M | Micro cap | −40.63% |
| XBIO | Xenetic Biosciences, Inc. | $8.93M | Micro cap | +33.57% |
| CURX | Curanex Pharmaceuticals Inc | $7.45M | Micro cap | +18.16% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +260.94% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.